Harmol and harmine hydrochloride are inverse agonists of benzodiazepine receptors that are involved in steroid synthesis, so it is also possible that their inhibition at the peripheral level could account for the inhibition of AR-mediated prostate cancer cell growth [50,51,52]. Here, AR is linked to Familial prostate cancer.